跳至主要内容
临床试验/CTRI/2018/07/014869
CTRI/2018/07/014869尚未招募2 期

An open clinical study to evaluate the clinical efficacy of siddha sasthric formulation karappan kudineer chooranam (internal ) and karappan ennai (external )for the treatment of sattai karappan

A AMMU1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年7月17日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
the therapeutic efficacy of trial drug Karappan kudineer chooranam(internal)karappan ennai (external)on Sattai karappan

研究概览

简要总结

The study is  prospective open labeled non randomized phase 2 an open clinical study to evaluate the clinical efficacy of siddha sasthric formulation Karappan kudineer chooranam(internal) Karappan ennai (external) 3-7 years 30ml,7-12years 60ml,twice a day (morning and evening)internally and Oil-externally for 21 days in 40 patients during the trail period of 13months that will be conducted in government siddha medical college and hospital palayamkottai Tamil nadu The primary outcome will be the therapeutic efficacy of trial drug Karappan kudineer chooranam(internal) karappan ennai(external)on Sattai karappan The secondary outcome will be the evaluation of siddha diagnostic parameters

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
3.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Patient with appropriate symptoms of intense itching erythema papules papulovesicles crusted lesion all over the body ulceration exudation constipation.

排除标准

  • children above 12 years scabies psoriasis secondary bacterial infection nummular dermatitis contact dermatitis seborric dermatitis furunculosis photo dermatitis neuro dermatitis.

结局指标

主要结局

the therapeutic efficacy of trial drug Karappan kudineer chooranam(internal)karappan ennai (external)on Sattai karappan

时间窗: 21 days

次要结局

  • Evaluation of siddha diagnostic parameters(21 days)

研究者

发起方
A AMMU
申办方类型
Other [PG scholar (stif fund)]

研究点 (1)

Loading locations...

相似试验

A clinical trail to study the effects of karappan... | 临床试验